191 related articles for article (PubMed ID: 21885276)
1. Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors.
Aubele DL; Truong AP; Dressen DB; Probst GD; Bowers S; Mattson MN; Semko CM; Sun M; Garofalo AW; Konradi AW; Sham HL; Zmolek W; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Bova MP; Hemphill SS; Basi G
Bioorg Med Chem Lett; 2011 Oct; 21(19):5791-4. PubMed ID: 21885276
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline gamma-secretase inhibitors.
Truong AP; Aubele DL; Probst GD; Neitzel ML; Semko CM; Bowers S; Dressen D; Hom RK; Konradi AW; Sham HL; Garofalo AW; Keim PS; Wu J; Dappen MS; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Hemphill SS; Bova MP; Bard F; Yednock TA; Basi G
Bioorg Med Chem Lett; 2009 Sep; 19(17):4920-3. PubMed ID: 19660943
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.
Ye XM; Konradi AW; Sun M; Yuan S; Aubele DL; Dappen M; Dressen D; Garofalo AW; Jagodzinski JJ; Latimer L; Probst GD; Sham HL; Wone D; Xu YZ; Ness D; Brigham E; Kwong GT; Willtis C; Tonn G; Goldbach E; Quinn KP; Zhang HH; Sauer JM; Bova M; Basi GS
Bioorg Med Chem Lett; 2013 Feb; 23(4):996-1000. PubMed ID: 23312944
[TBL] [Abstract][Full Text] [Related]
4. Amino-caprolactam γ-secretase inhibitors showing potential for the treatment of Alzheimer's disease.
Neitzel ML; Aubele DL; Marugg JL; Jagodzinski JJ; Konradi AW; Pleiss MA; Szoke B; Zmolek W; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Bova MP; Hemphill S; Basi G
Bioorg Med Chem Lett; 2011 Jun; 21(12):3715-20. PubMed ID: 21571529
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L
Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious gamma-secretase inhibitors.
Ye XM; Konradi AW; Smith J; Xu YZ; Dressen D; Garofalo AW; Marugg J; Sham HL; Truong AP; Jagodzinski J; Pleiss M; Zhang H; Goldbach E; Sauer JM; Brigham E; Bova M; Basi GS
Bioorg Med Chem Lett; 2010 Apr; 20(7):2195-9. PubMed ID: 20207136
[TBL] [Abstract][Full Text] [Related]
8. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
9. Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): metabolically stable γ-secretase Inhibitors that selectively inhibit the production of amyloid-β over Notch.
Probst G; Aubele DL; Bowers S; Dressen D; Garofalo AW; Hom RK; Konradi AW; Marugg JL; Mattson MN; Neitzel ML; Semko CM; Sham HL; Smith J; Sun M; Truong AP; Ye XM; Xu YZ; Dappen MS; Jagodzinski JJ; Keim PS; Peterson B; Latimer LH; Quincy D; Wu J; Goldbach E; Ness DK; Quinn KP; Sauer JM; Wong K; Zhang H; Zmolek W; Brigham EF; Kholodenko D; Hu K; Kwong GT; Lee M; Liao A; Motter RN; Sacayon P; Santiago P; Willits C; Bard F; Bova MP; Hemphill SS; Nguyen L; Ruslim L; Tanaka K; Tanaka P; Wallace W; Yednock TA; Basi GS
J Med Chem; 2013 Jul; 56(13):5261-74. PubMed ID: 23713656
[TBL] [Abstract][Full Text] [Related]
10. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR study of tricyclic sulfones as γ-secretase inhibitors: C-6 and C-8 positions.
Su J; Tang H; McKittrick BA; Xu R; Clader JW; Greenlee WJ; Hyde L; Zhang L
Bioorg Med Chem Lett; 2011 Jun; 21(11):3447-51. PubMed ID: 21515050
[TBL] [Abstract][Full Text] [Related]
12. Discovery of sulfonamide-pyrazole gamma-secretase inhibitors.
Mattson MN; Neitzel ML; Quincy DA; Semko CM; Garofalo AW; Keim PS; Konradi AW; Pleiss MA; Sham HL; Brigham EF; Goldbach EG; Zhang H; Sauer JM; Basi GS
Bioorg Med Chem Lett; 2010 Apr; 20(7):2148-50. PubMed ID: 20206516
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
Kreft A; Harrison B; Aschmies S; Atchison K; Casebier D; Cole DC; Diamantidis G; Ellingboe J; Hauze D; Hu Y; Huryn D; Jin M; Kubrak D; Lu P; Lundquist J; Mann C; Martone R; Moore W; Oganesian A; Porte A; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Woller K; Xu Z; Zhou H; Steven Jacobsen J
Bioorg Med Chem Lett; 2008 Jul; 18(14):4232-6. PubMed ID: 18556202
[TBL] [Abstract][Full Text] [Related]
14. Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta.
Bakshi P; Jin C; Broutin P; Berhane B; Reed J; Mullan M
Bioorg Med Chem; 2009 Dec; 17(23):8102-12. PubMed ID: 19853461
[TBL] [Abstract][Full Text] [Related]
15. Quantitative pharmacokinetic/pharmacodynamic analyses suggest that the 129/SVE mouse is a suitable preclinical pharmacology model for identifying small-molecule γ-secretase inhibitors.
Lu Y; Zhang L; Nolan CE; Becker SL; Atchison K; Robshaw AE; Pustilnik LR; Osgood SM; Miller EH; Stepan AF; Subramanyam C; Efremov I; Hallgren AJ; Riddell D
J Pharmacol Exp Ther; 2011 Dec; 339(3):922-34. PubMed ID: 21930801
[TBL] [Abstract][Full Text] [Related]
16. Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretase.
Bergstrom CP; Sloan CP; Wang HH; Parker MF; Smith DW; Zheng M; Hansel SB; Polson CT; Barber LE; Bursuker I; Guss VL; Corsa JA; Barten DM; Felsenstein KM; Roberts SB
Bioorg Med Chem Lett; 2008 Jan; 18(1):175-8. PubMed ID: 18023581
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1).
Ma L; Yang Z; Li C; Zhu Z; Shen X; Hu L
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):643-8. PubMed ID: 21222511
[TBL] [Abstract][Full Text] [Related]
18. Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's disease.
Brodney MA; Auperin DD; Becker SL; Bronk BS; Brown TM; Coffman KJ; Finley JE; Hicks CD; Karmilowicz MJ; Lanz TA; Liston D; Liu X; Martin BA; Nelson RB; Nolan CE; Oborski CE; Parker CP; Richter KE; Pozdnyakov N; Sahagan BG; Schachter JB; Sokolowski SA; Tate B; Van Deusen JW; Wood DE; Wood KM
Bioorg Med Chem Lett; 2011 May; 21(9):2631-6. PubMed ID: 21269825
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.
Thompson LA; Liauw AY; Ramanjulu MM; Kasireddy-Polam P; Mercer SE; Maduskuie TP; Glicksman M; Roach AH; Meredith JE; Liu RQ; Combs AP; Higaki JN; Cordell B; Seiffert D; Zaczek RC; Robertson DW; Olson RE
Bioorg Med Chem Lett; 2006 May; 16(9):2357-63. PubMed ID: 16473009
[TBL] [Abstract][Full Text] [Related]
20. Tricyclic sulfones as orally active gamma-secretase inhibitors: synthesis and structure-activity relationship studies.
Sasikumar TK; Qiang L; Burnett DA; Cole D; Xu R; Li H; Greenlee WJ; Clader J; Zhang L; Hyde L
Bioorg Med Chem Lett; 2010 Jun; 20(12):3632-5. PubMed ID: 20493690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
